Journal: Frontiers in Microbiology
Article Title: Current progress on the microbial therapies for acute liver failure
doi: 10.3389/fmicb.2024.1452663
Figure Lengend Snippet: Application of microbiota in clinical trials of liver diseases.
Article Snippet: Live lactic acid bacteria probiotics (other names:VSL-3, VSL#3) ( ) , America , Original/Active company: Vsl Pharmaceuticals Inc , NAFLD; HE; Cirrhosis , Multiplex probiotic , Consisting of 8 different probiotic strains, including Lactobacillus and Bifidobacterium , to regulate intestinal microbiome , NAFLD:Marketing approval , NAFLD:Marketing approval HE: clinical stage 1 (ChiCTR2000040960) Cirrhosis: clinical stage 2 (EUCTR2010-022886-92-GB; NCT01701297).
Techniques: Clinical Proteomics, Bacteria, Probiotics, Multiplex Assay, Infection, Capsules